Early data from the ADAPT JR trial suggest efgartigimod may benefit adolescents with generalized myasthenia gravis, a rare ...
PHM continues to advance with diverse research impacting clinical care, quality improvement, and health equity. The top 10 ...
A study showed babies who have ABO-mediated HDFN should be checked for signs of jaundice two to three times during the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback